Health Economics and Market Access for Orphan Drugs

Orphan drug development comes with high costs that pose challenges to market access. Health economics plays a pivotal role in assessing the value and cost-effectiveness of treatments. New models of pricing, reimbursement strategies, and health technology assessments (HTAs) help balance affordability and company sustainability. Patient assistance programs and partnerships with non-profits are essential for equitable access to life-saving treatments. Addressing economic and market challenges ensures that orphan drugs can benefit those who need them most.

    Related Conference of Health Economics and Market Access for Orphan Drugs

    November 21-22, 2024

    7th Pathology and Infectious Disease Conference

    Dubai, UAE
    November 28-29, 2024

    20th World Congress on Infection Prevention and Control

    Paris, France
    March 13-14, 2025

    9th International Conference on Rare Diseases

    Prague, Czech Republic
    March 17-18, 2025

    12th International Congress on Infectious Diseases

    Berlin, Germany
    April 14-15, 2025

    15th European Epidemiology and Public Health Congress

    Budapest, Hungary
    June 02-03, 2025

    17th Euro-Global Conference on Infectious Diseases

    Amsterdam, Netherlands
    June 02-03, 2025

    14th World Congress on Rare Diseases and Orphan Drugs

    Amsterdam, Netherlands

    Health Economics and Market Access for Orphan Drugs Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in